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Chagas Disease 
in Ancient Hunter-
Gatherer 
Population, Brazil 
To the Editor: Chagas disease, 
caused by the protozoan Trypanosoma 
cruzi, and ﬁ   rst described by Carlos 
Chagas in 1909, is endemic to Latin 
America. As a results of multination-
al control initiatives launched in the 
1990s, the disease prevalence has been 
reduced. This campaign was focused 
on the interruption of T. cruzi vecto-
rial transmission by eliminating domi-
ciled triatomines. In 2006, Brazil was 
declared to be free from T. cruzi trans-
mission by Triatoma infestans (1). T. 
cruzi is a heterogeneous taxon with 
multiple mammal hosts and vectors, 
besides alternative routes of infection 
and infective forms. In the Brazil-
ian Amazon region, where domiciled 
triatomines have not been reported, 
human cases of Chagas disease have 
been increasing (2). This increase has 
been attributed to uncontrolled migra-
tion and deforestation (2). Addition-
ally, recent outbreaks of Chagas dis-
ease attributed to oral transmission in 
previously non–disease-endemic areas 
out of the Amazon region (3) indicate 
that a new epidemiologic proﬁ  le  is 
emerging in Brazil. 
T. cruzi has 2 main genotypes, T. 
cruzi I and T. cruzi II, and these sub-
populations display distinct biologic, 
biochemical, and genetic proﬁ  les. In 
Brazil, T. cruzi I is widespread among 
wild mammals and sylvatic vectors of 
all biomes. Moreover, this genotype is 
commonly isolated from humans and 
wild mammals in the Amazon Basin. 
In contrast, T. cruzi II, has a focal 
distribution in nature but is the main 
agent of human infection in other Bra-
zilian regions (4).
In this report, we describe the 
ﬁ  nding of T. cruzi in human remains 
dating back 4,500–7,000 years that 
were obtained from a Brazilian ar-
cheological site and, the recovery of 
an ancient DNA (aDNA) sequence 
corresponding to the parasite lineage 
type I. The mummy, called AM1, 
was a woman ≈35 years of age from 
a hunter-gatherer population. She was 
found in Abrigo do Malhador archeo-
logical site, Peruaçu Valley, Minas 
Gerais State (5). This region, where 
the semiarid ecosystem is predomi-
nant, has a dry climate, karst relief (an 
area of limestone terrain characterized 
by sinks, ravines, and underground 
streams), and soil with a basic pH. 
These conditions have contributed to 
the preservation of specimens.
The remains were excavated in 
1985 and maintained in an environ-
ment protected from light and humid-
ity. In 2005, after taking precautions to 
avoid contamination with exogenous 
DNA or cross-contamination between 
samples, we collected ≈6 cm of a rib 
fragment from AM1. All experiments 
were conducted in a restricted area 
that was isolated from the major labo-
ratory, where post-PCR experiments 
were performed. T. cruzi had never 
been used in either laboratory. Mito-
chondrial DNA haplotypes of labora-
tory staff were determined to control 
contamination. PCR-positive controls 
(T. cruzi) were not used. The rib sur-
face was gently scraped to remove 
impurities and decontaminated with 
bleach (6% NaOCl) and UV light (15 
min for each side). We processed 300 
mg of bone powder according to the 
extraction protocol of dehybernation 
B solution of the Geneclean Kit for 
Ancient DNA (Bio101, La Jolla, CA, 
USA). By using speciﬁ  c set of primers 
(6), a 350-bp miniexon gene fragment 
was successfully recovered by PCR 
(Figure); the fragment corresponded 
to the T. cruzi I lineage, according 
to miniexon gene typing assay (6). 
Moreover, nucleotide sequence analy-
sis (341 bp) (GenBank accession no. 
EF626693), showed 98% similarity 
with T. cruzi I sequences in GenBank. 
Additionally, total aDNA hybridiza-
tion with T. cruzi probes (miniexon 
and total kinetoplast DNA) conﬁ  rmed 
the infection. Sequence analysis of the 
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Figure. Trypanosoma cruzi miniexon gene typing assay. Lanes 1 and 2, T. cruzi II (300 bp) 
and T. cruzi I (350 bp) markers, respectively; lane 3, T. cruzi I cloned fragment recovered 
from Brazilian mummy; lane 4, 100-bp ladder.LETTERS
human mitochondrial DNA HVS-I re-
gion characterized this person as be-
longing to haplogroup B (GenBank 
accession no. EU359272), one of the 
founder human haplogroups in the 
Americas.
The antiquity of human T. cruzi 
infection in South America has been 
demonstrated on the basis of pale-
onthologic studies. Clinical manifesta-
tions of Chagas disease were observed 
in Chilean mummies from pre-Colum-
bian times (7). Moreover, a T. cruzi ki-
netoplast DNA region was recovered 
in Chilean and Peruvian mummies 
from up to 9,000 years ago (8,9).
In Brazil, the current epidemiolog-
ic scenario concerning Chagas disease 
in indigenous populations involves 
ecologic aspects of their settlements, 
along with nomad habits, which pre-
vent triatomine nesting and, therefore, 
the infection. The beginning of T. cru-
zi transmission to humans is attributed 
to the domiciliation of T. infestans as a 
consequence of precarious mud dwell-
ings, built after European colonization 
(10). In this report, we showed that T. 
cruzi human infection in Brazil is an-
cient, dating back at least 4,500 years, 
and therefore occurring in hunter-gath-
erer populations largely preceding T. 
infestans domiciliation. The presence 
of the T. cruzi I genotype infecting hu-
mans 4,500–7,000 years ago in Minas 
Gerais State, where this genotype is 
currently absent (6), suggests that the 
distribution pattern of T. cruzi geno-
types in humans has changed in time 
and place. Moreover, the recovery of 
an aDNA sequence and the possibility 
of genotyping parasites from human 
remains make it possible to recon-
struct the early dispersion patterns of 
T. cruzi subpopulations. On the basis 
of our results, one may speculate that 
the current outbreaks of human T. cru-
zi infection, independent of triatomine 
domiciliation, are the reemergence of 
the ancient epidemiologic scenario of 
Chagas disease in Brazil.
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Coxiella burnetii 
in Wild-caught 
Filth Flies 
To the Editor: Coxiella burnetii, 
the agent of Q fever, is a bacterium 
and a potential agent of bioterrorism. 
The most frequent signs of infection 
in domestic animals are abortion and 
reduced fertility (1). Clinical signs of 
Q fever in humans vary from mild fe-
vers to pneumonia, hepatitis, or death; 
atypical cases occur as other disorders, 
such as cholecystitis (1,2). Aerosols 
are the most common route of expo-
sure, but oral transmission occurs (1).
Some ﬂ  ies feed on the feces, milk, 
carcasses, or blood of domestic ani-
mals that can be infected with C. bur-
netii. These ﬂ  ies regurgitate and defe-
cate when feeding and are mechanical 
vectors of bacteria (3,4). Flies have 
been shown to harbor, mechanically 
transport, and even support the growth 
of C. burnetii (4–6). It is known that 
house  ﬂ  ies  (Musca domestica) are 
possible mechanical vectors of C. bur-
netii because this organism survived 
32 days in house ﬂ  ies and viable bac-
teria were shed by ﬂ  ies for 15 days (4). 
There are no studies of C. burnetii in 
ﬁ  eld-collected  ﬂ   ies. To examine the 
prevalence of C. burnetii in ﬁ  eld-col-
lected ﬂ  ies, we tested ﬂ  ies from farms, 
forests, ranches, and zoos.
Flies that develop on animal 
dung, carcasses, feces, blood, or gar-
bage are often called ﬁ  lth ﬂ  ies. Adult 
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